We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Thorne HealthTech has entered into a definitive agreement with L Catterton, a prominent global investment firm, under which L Catterton will initiate a tender offer to acquire all
South Korea-based GC Biopharma has signed a Memorandum of Understanding (MOU) with Eubiologics to establish a collaborative effort for the co-production of Euvichol, an oral cholera vaccine. Under
AGC Biologics, a biopharmaceutical contract development and manufacturing organisation (CDMO), has announced a substantial expansion in its capabilities with the introduction of three new Grade B cell therapy
Sanyou Biopharmaceuticals and Sinorda Biomedicine have entered into a strategic cooperation agreement to propel the progress of their innovative bispecific antibody drug project. Under the terms of the
LEO Pharma has agreed to acquire Timber Pharmaceuticals, a company listed on US stock exchanges, to advance its medical dermatology pipeline. The successful completion of the acquisition is
ABB India has secured a significant automation contract from Reliance Life Sciences (RLS) for the purpose of automating their new manufacturing facilities situated in Nashik, Maharashtra. The 160-acre
Lupin has completed the acquisition of the diabetes brands Ondero and Ondero Met from Boehringer Ingelheim International. The acquisition encompasses the trademark rights associated with these brands. Lupin
Abcuro, a biotechnology company in the clinical stage, focused on developing therapies that target autoimmune diseases and cancer via precise adjustments to cytotoxic T and NK cells, has
CytoMed Therapeutics, headquartered in Singapore, has entered into a Memorandum of Understanding (MOU) with Hangzhou CNK Therapeutics (CNK) to boost its allogeneic CAR γδ T in vivo persistency.
Gritstone bio, a biotechnology company in the clinical stage, has entered into an agreement with Genevant Sciences, a company specialising in nucleic acid delivery. As per the agreement